Most importantly, in our study, the expression levels of SELENBP1 had no significant relationship with disease stage in both LUAD and LUSC from TCGA database and collected clinical NSCLC tissues, which hinted that SELENBP1 might be an early gene in the development of NSCLC. This evidence concerns the gene SELENBP1 and non-small cell lung carcinoma.